跳至主要内容
临床试验/NCT00963144
NCT00963144已完成不适用

Diagnosis and Response to Treatment Using a Reliable Gerd Questionnaire-an In Clinical Practise Study

AstraZeneca1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2009年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
250
试验地点
1
主要终点
To determine the applicability and utility of Gerd Q in the diagnosis of GERD and assessment of treatment response

研究概览

简要总结

The purpose of the study is to determine the applicability and utility of Gerd Q in the diagnosis of GERD and in the assessment of treatment response.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients of either gender aged between 18-79 years of age
  • Patients must be having symptoms of gastroesophageal reflux disease

排除标准

  • 未提供

结局指标

主要结局

To determine the applicability and utility of Gerd Q in the diagnosis of GERD and assessment of treatment response

时间窗: The applicability and utility of the Gerd Questionnaire will be done on 2 vists- Day 1 and Day 30

次要结局

  • To assess and monitor the treatment response of patients diagnosed with GERD(The monitoring and assessment of treatment response using the Gerd Questionnaire will be done on 2 vists-Day 1 and Day 30)

研究者

发起方
AstraZeneca
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验